Zhang, P., Zhang, P., Xie, D., Xie, D., Li, Q., & Li, Q. (2021). Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A.
Chicago-čujuhus (17. p.)Zhang, Peng-Fei, Peng-Fei Zhang, Dan Xie, Dan Xie, Qiu Li, juo Qiu Li. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.
MLA-čujuhus (9. p.)Zhang, Peng-Fei, et al. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.